DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,615,000 | +132.0% | 80,116 | +153.6% | 0.01% | +75.0% |
| Q4 2020 | $696,000 | -63.3% | 31,591 | -70.0% | 0.00% | -66.7% |
| Q3 2020 | $1,896,000 | -58.3% | 105,409 | -57.4% | 0.01% | -73.3% |
| Q1 2020 | $4,550,000 | -78.9% | 247,695 | -74.7% | 0.04% | -69.6% |
| Q4 2019 | $21,586,000 | +868.4% | 979,870 | +531.0% | 0.15% | +722.2% |
| Q3 2019 | $2,229,000 | -62.4% | 155,287 | -61.6% | 0.02% | -35.7% |
| Q1 2019 | $5,926,000 | – | 404,426 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
| COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
| GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
| DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
| Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
| RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
| Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
| Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
| Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |